Sight Sciences, Inc. (SGHT) Misses Q1 EPS by 7c ; Offers Guidance May 6, 2026 04:23PM
Sight Sciences presents glaucoma and dry eye data at ASCRS meeting Apr 1, 2026 04:05PM
Sight Sciences wins $34 million patent case against Alcon Mar 30, 2026 07:05AM
William Blair Reiterates Outperform Rating on Sight Sciences Inc. (SGHT) following earnings call Mar 5, 2026 11:55AM
Sight Sciences Inc. (SGHT) PT Lowered to $6.50 at Citi Mar 5, 2026 10:13AM


Mar 4, 2026 04:27PM Sight Sciences, Inc. (SGHT) Tops Q4 EPS by 7c
Mar 2, 2026 09:10AM Sight Sciences Inc. (SGHT) PT Raised to $8 at Stifel Following Optometrist Survey
Jan 30, 2026 05:47AM William Blair Resumes Sight Sciences Inc. (SGHT) at Outperform
Jan 13, 2026 07:06AM Sight Sciences reports 7% Q4 revenue growth to $20.4 million
Jan 5, 2026 07:23AM Piper Sandler Upgrades Sight Sciences Inc. (SGHT) to Overweight, 'Dry Eye Enthusiasm Building + Improving Core Biz'
Nov 11, 2025 07:01AM Sight Sciences reports positive results for OMNI glaucoma system
Nov 7, 2025 05:18AM Needham Reiterates Hold Rating on Sight Sciences Inc. (SGHT)
Nov 6, 2025 04:27PM Sight Sciences, Inc. (SGHT) Tops Q3 EPS by 10c ; Offers Guidance
Oct 17, 2025 07:01AM Sight Sciences receives Medicare fee schedules for dry eye procedure
Sep 17, 2025 07:01AM Sight Sciences study shows OMNI system reduces eye pressure long-term
Sep 9, 2025 07:05AM UnitedHealthcare expands glaucoma surgery coverage to include OMNI system
Aug 8, 2025 08:43AM Lake Street Capital Markets Upgrades Sight Sciences Inc. (SGHT) to Buy
Aug 7, 2025 04:21PM Sight Sciences, Inc. (SGHT) Tops Q2 EPS by 3c ; Offers Guidance
Jul 30, 2025 07:00AM Sight Sciences study shows TearCare system cuts dry eye treatment costs
Jul 29, 2025 07:02AM Sight Sciences reports 24-month dry eye treatment durability data
Jun 18, 2025 09:54AM Sight Sciences Inc. (SGHT) PT Raised to $4 at Piper Sandler
May 9, 2025 06:47AM Needham Reiterates Hold Rating on Sight Sciences Inc. (SGHT)
May 8, 2025 04:20PM Sight Sciences, Inc. (SGHT) Misses Q1 EPS by 5c ; Offers Guidance
Apr 22, 2025 04:06PM Sight Sciences (SGHT) appoints Gary Burbach to Board
Mar 6, 2025 09:56AM Sight Sciences Inc. (SGHT) PT Lowered to $4 at Stifel
Mar 5, 2025 04:12PM Sight Sciences, Inc. (SGHT) Misses Q4 EPS by 1c
Feb 18, 2025 07:28AM Stifel Reiterates Buy Rating on Sight Sciences Inc. (SGHT)
Jan 15, 2025 08:48AM Sight Sciences Inc. (SGHT) PT Lowered to $3 at Lake Street Capital Markets
Jan 14, 2025 08:07AM Sight Sciences (SGHT) Announces Preliminary, Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
Jan 7, 2025 04:06PM Sight Sciences (SGHT) Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System
Dec 6, 2024 03:39AM UBS Starts Sight Sciences Inc. (SGHT) at Buy
Nov 8, 2024 08:26AM Sight Sciences Inc. (SGHT) PT Lowered to $5.50 at Piper Sandler
Nov 8, 2024 06:58AM Sight Sciences, Inc. (SGHT) Misses Q3 EPS by 1c
Nov 4, 2024 09:06AM Lake Street Capital Markets Downgrades Sight Sciences Inc. (SGHT) to Hold
Oct 4, 2024 09:21AM Lake Street Capital Markets Reiterates Buy Rating on Sight Sciences Inc. (SGHT)
Aug 1, 2024 04:24PM Sight Sciences, Inc. (SGHT) Tops Q2 EPS by 5c, narrows guidance
Jul 10, 2024 02:13PM Sight Sciences (SGHT) Gains as CMS Updates Seen as Positive